In the current month’s ABA Law Practice Journal, Susan Saltonstall Duncan of Rainmaking Oasis wrote a nice, concise commentary about Pfizer’s relatively new model for engaging outside counsel.  While other corporate legal departments have branded their particular models for internal operations (DuPont) and engaging and paying for law firm representation (FMC Technologies’ ACES program), Pfizer seems uniquely committed […]

Read More →

Being a sports-savvy group of New Englanders, we Brightleaf folks pay attention to goings-on around the Red Sox clubhouse. Like most people here, we were beside ourselves in 2004, thrilled to be thrilled again in 2007, and in 2011, we felt like the “25 guys, 25 taxis” team was making a resurgence. Needless to say, […]

Read More →